Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Financing › Details

Celeris Therapeutics–SEVERAL: investment, 202103 pre-seed financing round €400k from R42 Group + Longevitytech.fund

 

Period Period 2021-03-31
  Successor Celeris Therapeutics–SEVERAL: investment, 202202 seed financing round $4.4m led by Pace Ventures Enigma + i&i Biotech Fund + Apex Ventures
Organisations Money taker Celeris Therapeutics GmbH
  Group Celeris Therapeutics (CelerixTx) (Group)
  Money source SEVERAL
Products Product Celeris One™ platform
  Product 2 venture capital
Document Source Der Brutkasten [Redaktion]. (3/31/21). "News: Grazer Biotech-Startup erhält 400.000 Euro Pre-Seed-Investment. Celeris Therapeutics will mit seiner Plattform ermöglichen, dass bessere Medikamente schneller auf den Markt kommen - und konnte damit internati
     

   
Record changed: 2024-01-09

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Celeris Therapeutics (CelerixTx) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner Voices Peter Seeberger Chemistry Transformation 650x300px




» top